Bristol Myers Squibb (BMY)

Retained Earnings

$20.32B

Quarterly · Period ending: · USD

BMY logo

BMY Retained Earnings

Latest reported$20.32B
BMY Quarterly Retained Earnings ($4.59B → $20.32B)
High-resolution chart · PNG

BMY retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
20,316,000,000
18,287,000,000
16,896,000,000
17,093,000,000
16,154,000,000
16,106,000,000
14,912,000,000
16,097,000,000
16,103,000,000
15,640,000,000
28,766,000,000
28,218,000,000
27,449,000,000
26,568,000,000
25,503,000,000
24,675,000,000
24,217,000,000
23,948,000,000
23,820,000,000
22,625,000,000
22,168,000,000
22,204,000,000
21,281,000,000
32,414,000,000
31,565,000,000
32,671,000,000
34,474,000,000
36,555,000,000
35,870,000,000
35,109,000,000
34,065,000,000
33,292,000,000
32,044,000,000
32,323,000,000
31,160,000,000
34,141,000,000
33,934,000,000
33,658,000,000
33,513,000,000
33,272,000,000
32,706,000,000
32,176,000,000
31,613,000,000
32,446,000,000
32,361,000,000
33,110,000,000
32,541,000,000
33,147,000,000
33,026,000,000
33,291,000,000
32,952,000,000
32,826,000,000
32,715,000,000
32,761,000,000
32,733,000,000
32,381,000,000
33,661,000,000
33,595,000,000
33,069,000,000
32,797,000,000
32,392,000,000
32,055,000,000
31,636,000,000
31,721,000,000
31,322,000,000
30,949,000,000
30,760,000,000
23,287,000,000
22,936,000,000
22,571,000,000
22,549,000,000
21,919,000,000
19,957,000,000
19,808,000,000
19,762,000,000
20,463,000,000
20,161,000,000
20,011,000,000
19,845,000,000
20,531,000,000
20,743,000,000
20,627,000,000
20,464,000,000
20,512,000,000
20,096,000,000
19,638,000,000
19,651,000,000
20,056,000,000
19,842,000,000
19,859,000,000
19,439,000,000
19,756,000,000
19,415,000,000
19,079,000,000
18,503,000,000
19,023,000,000
20,627,000,000
20,729,000,000
18,958,000,000
19,756,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.